Oxford Gene Sues BioArray Over BeadChip Patent
OGT, which is part-owned by its eponymous university, sued Warren, N.J.-based BioArray Wednesday in the U.S. District Court for the District of Delaware.
The British biotech asserted three patents, demanding trebled damages with prejudgment interest, permanent injunctive relief and attorneys fees' and costs.
BioArray's BeadChip products violate OGT's proprietary rights to...
To view the full article, register now.